After Hours
$
9.34
Change
+0.10 +1.08%
Volume
Volume 48,179
Mar 23, 2023, 7:23 p.m.
Quotes are delayed by 20 min
Previous close
$ 8.89
$ 9.24
Change
+0.35 +3.94%
Day low
Day high
$9.03
$9.77

52 week low
52 week high
$3.85
$14.20

Market cap
$2.17B
Average volume
4.42M
P/E ratio
N/A
Rev. per Employee
$166,845
EPS
-1.40
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on PACB
-
Illumina Faces Rival Gene Sequencers and Price Competition
- Barron's Online
-
Illumina Attracts Challengers for DNA Sequencing Ahead of Earnings
- Barron's Online
-
Why Chip Maker Nvidia Was at a Healthcare Conference
- Barron's Online
-
Pacific Bio Pushes Back at Illumina With New No-Compromise Gene Readers
- Barron's Online
-
Illumina Slashes Gene Sequencing Prices. The Stock Is a Buy.
- Barron's Online
-
SoftBank CEO to Take Stake in Vision Fund 2
- Barron's Online
-
Why ARK Innovation Is a Different Fund Today Than It Was a Year Ago
- Barron's Online
-
Pacific Biosciences stock price target raised to $48 from $42 at J.P. Morgan
- Tomi Kilgore
-
ARK ETFs Might Be Too Popular for Their Own Good
- Barron's Online
-
Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5
- Tonya Garcia
-
Lumber Liquidators, Campbell Soup and Other 13D Filings
- Barron's Online
-
Carl Icahn Takes Position in Conduent
- Barron's Online
- Loading more headlines...
Analyst Ratings
Other News on PACB
-
10-K: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
10-Q: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
PacBio beats on bottom line in Q3 even as net loss widens 8% YoY
- Seeking Alpha
-
Pacific Biosciences of California Q3 2022 Earnings Preview
- Seeking Alpha
-
Veracyte: The FDA Is Stepping In
- Seeking Alpha
-
PacBio to launch gene-sequencing system Revio
- Seeking Alpha
-
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update
- Seeking Alpha
-
Tracking Baker Brothers Portfolio - Q2 2022 Update
- Seeking Alpha
- Loading more headlines...
Press Releases on PACB
-
Resolve Biosciences Announces Appointment of John Stark as Chief Executive Officer
- BusinessWire - BZX
-
PacBio Announces a New Informatics Analysis Method for Highly Homologous Genes
- PR Newswire - PRF
-
PacBio To Begin Commercial Shipment of Revio Systems
- PR Newswire - PRF
-
Friday's ETF with Unusual Volume: DWAS
- MarketNewsVideo.com
-
PacBio to Present at Cowen's 43rd Annual Health Care Conference
- PR Newswire - PRF
-
Tuesday's ETF Movers: COPX, ARKK
- MarketNewsVideo.com
-
PacBio Announces Fourth Quarter and Fiscal Year 2022 Financial Results
- PR Newswire - PRF
-
PacBio to Expand MAS-Seq Technology to 16S rRNA and Bulk RNA-Seq Solutions
- PR Newswire - PRF
-
PacBio to Present at 41st Annual J.P. Morgan Healthcare Conference
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com